Drawing for VALGENESIS SMART GXP

USPTO serial 99105200

VALGENESIS SMART GXP

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
FLETCHER, TRACY L
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with VALGENESIS SMART GXP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas E. Watson

Thomas E. Watson Amin, Turocy & Watson, LLP200 Park AvenueSuite 300Beachwood, OH 44122

Goods and services

ClassDescriptionStatusFirst use
009Downloadable web-based database software using artificial intelligence for analytics and improving the operational efficiency of validating an inventory tracking system; Downloadable cloud-based software using artificial intelligence for analytics and improving the operational efficiency of validating an inventory tracking system; Downloadable enterprise software for analytics and improving the operational efficiency of validating an inventory tracking system; Downloadable mobile applications for analytics and improving the operational efficiency of validating an inventory tracking system; Downloadable application software for analytics and improving the operational efficiency of validating an inventory tracking system; Recorded computer firmware for analytics and improving the operational efficiency of validating an inventory tracking system; Downloadable server-based software platform for analytics and improving the operational efficiency of validating an inventory tracking systemACTIVE—
042Consultation and advisory services in the field of computer software regarding software implementation; Consultancy in the field of artificial intelligence technology; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for paperless validation of software required by life sciences companies in order to meet the regulatory requirement of life sciences regulators for remote inspection of pharmaceuticals during manufacture, for performing quality control operations, for temperature measurement, for maintaining logs of equipment, for measuring critical quality and process control parameters, for calibrating equipment used in the manufacture of medical devices and biopharmaceutical products, for document management, for enterprise resource management, for laboratory information management, for managing equipment for automated testing of inventory tracking systems, and for analyzing risk management data; Software as a service (SaaS) services featuring software using artificial intelligence for paperless validation to automate document creation, execution, and evidence processing and analyze them for regulatory compliance and adherence to internal processes for remote inspection of pharmaceuticals during manufacture, for performing quality control operations, for temperature measurement, for maintaining logs of equipment, for measuring critical quality and process control parameters, for calibrating equipment used in the manufacture of medical devices and biopharmaceutical products, for document management, for enterprise resource management, for laboratory information management for managing equipment for automated testing of inventory tracking systems, and for analyzing risk management data; Providing temporary use of non-downloadable web-based database software used for analytics and improving the operational efficiency of validating an inventory tracking system; Providing temporary use of non-downloadable computer software using artificial intelligence for paperless validation to automate document creation, execution, and evidence processing and analyze them for regulatory compliance and adherence to internal processes, for remote inspection of pharmaceuticals during manufacture, for performing quality control operations, for temperature measurement, for maintaining logs of equipment, for measuring critical quality and process control parameters, for calibrating equipment used in the manufacture of medical devices and biopharmaceutical products, for document management, for enterprise resource management, for laboratory information management for managing equipment for automated testing of inventory tracking systems, and for analyzing risk management data; Providing temporary use of on-line non-downloadable cloud-based software using artificial intelligence for paperless validation to automate document creation, execution, and evidence processing and analyze them for regulatory compliance and adherence to internal processes, for remote inspection of pharmaceuticals during manufacture, for performing quality control operations, for temperature measurement, for maintaining logs of equipment, for measuring critical quality and process control parameters, for calibrating equipment used in the manufacture of medical devices and biopharmaceutical products, for document management, for enterprise resource management, for laboratory information management, for managing equipment for automated testing of inventory tracking systems, and for analyzing risk management data; Providing temporary use of online, non-downloadable enterprise software using artificial intelligence for paperless validation to automate document creation, execution, and evidence processing and analyze them for regulatory compliance and adherence to internal processes, for remote inspection of pharmaceuticals during manufacture, for performing quality control operations, for temperature measurement, for maintaining logs of equipment, for measuring critical quality and process control parameters, for calibrating equipment used in the manufacture of medical devices and biopharmaceutical products, for document management, for enterprise resource management, for laboratory information management, for managing equipment for automated testing of inventory tracking systems, and for analyzing risk management data; Providing a web site featuring temporary use of non-downloadable software using artificial intelligence for paperless validation to automate document creation, execution, and evidence processing and analyze them for regulatory compliance and adherence to internal processes, for remote inspection of pharmaceuticals during manufacture, for performing quality control operations, for temperature measurement, for maintaining logs of equipment, for measuring critical quality and process control parameters, for calibrating equipment used in the manufacture of medical devices and biopharmaceutical products, for document management, for enterprise resource management, for laboratory information management, for managing equipment for automated testing of inventory tracking systems, and for analyzing risk management dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 21, 2026EXT1SOU EXTENSION 1 FILED—
Jul 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 28, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 26, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2025DOCKASSIGNED TO EXAMINER—
Jul 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 26, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance